Exicure (XCUR) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

XCUR Stock Forecast

Exicure stock forecast is as follows: an average price target of $12.00 (represents a 10.50% upside from XCUR’s last price of $10.86) and

XCUR Price Target

Exicure Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jan 26, 2022	Keay Nakae	Chardan Capital	$12.00	$4.94	142.72%	10.50%

Row per page

Go to

The latest Exicure stock forecast, released on Jan 26, 2022 by Keay Nakae from Chardan Capital, set a price target of $12.00, which represents a 142.72% increase from the stock price at the time of the forecast ($4.94), and a 10.50% increase from XCUR last price ($10.86).

Exicure Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$10.86	$10.86	$10.86
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Exicure stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Exicure's last price of $10.86. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Exicure Financial Forecast

Exicure Revenue Forecast

	Sep 24	Jun 24	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Jun 18
Revenue	-	-	$21.77M	$2.02M	$2.47M	$2.56M	$3.68	$-3.68M	$79.00K	$997.00K	$140.00K	$2.44M	$4.85M	$9.18M	$310.00K	$527.00K	$434.00K	$25.00K	$19.00K
Avg Forecast	-	-	$3.90M	$3.90M	$4.10M	$4.30M	$3.50M	$6.99M	$1.55M	$1.64M	$3.09M	$2.37M	$1.73M	$1.43M	$100.00K	$250.00K	$300.00K	$100.00K	$16.76K
High Forecast	-	-	$6.62M	$3.90M	$4.10M	$4.30M	$3.50M	$6.99M	$1.55M	$1.64M	$3.09M	$2.37M	$1.73M	$1.43M	$100.00K	$250.00K	$300.00K	$100.00K	$20.12K
Low Forecast	-	-	$1.18M	$3.90M	$4.10M	$4.30M	$3.50M	$6.99M	$1.55M	$1.64M	$3.09M	$2.37M	$1.73M	$1.43M	$100.00K	$250.00K	$300.00K	$100.00K	$13.41K
# Analysts	-	-	1	1	1	1	1	1	1	1	1	1	10	10	9	9	9	9	20
Surprise %	-	-	5.58%	0.52%	0.60%	0.60%	0.00%	-0.53%	0.05%	0.61%	0.05%	1.03%	2.80%	6.41%	3.10%	2.11%	1.45%	0.25%	1.13%

Exicure's average Quarter revenue forecast for Jun 24 based on 0 analysts is -, with a low forecast of -, and a high forecast of -. XCUR's average Quarter revenue forecast represents a -100.00% decrease compared to the company's last Quarter revenue of $21.77M (Dec 22).

Exicure EBITDA Forecast

	Sep 24	Jun 24	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Jun 18
# Analysts	-	-	1	1	1	1	1	1	1	1	1	1	10	10	9	9	9	9	20
EBITDA	-	-	$19.04M	$-4.74M	$-7.02M	$-7.28M	$460.94K	$-23.54M	$-13.37M	$-11.64M	$-11.83M	$-8.12M	$-4.12M	$1.43M	$-9.57M	$-5.27M	$-4.93M	$-5.02M	$-6.57M
Avg Forecast	-	-	$2.11K	$-15.02K	$-15.79K	$-16.56K	$-13.48K	$-26.91K	$-5.98K	$-9.70M	$-11.90K	$-9.11K	$-6.67K	$-5.52K	$-385.00	$-962.00	$-1.16K	$-5.02M	$-5.69M
High Forecast	-	-	$3.58K	$-15.02K	$-15.79K	$-16.56K	$-13.48K	$-26.91K	$-5.98K	$-7.76M	$-11.90K	$-9.11K	$-6.67K	$-5.52K	$-385.00	$-962.00	$-1.16K	$-4.01M	$-4.55M
Low Forecast	-	-	$641.00	$-15.02K	$-15.79K	$-16.56K	$-13.48K	$-26.91K	$-5.98K	$-11.64M	$-11.90K	$-9.11K	$-6.67K	$-5.52K	$-385.00	$-962.00	$-1.16K	$-6.02M	$-6.83M
Surprise %	-	-	9025.59%	315.44%	444.86%	439.93%	-34.20%	874.76%	2237.04%	1.20%	994.45%	890.82%	617.92%	-258.38%	24867.53%	5481.29%	4268.40%	1.00%	1.15%

0 analysts predict XCUR's average Quarter EBITDA for Jun 24 to be -, with a high of - and a low of -. This is -100.00% lower than Exicure's previous annual EBITDA (Dec 22) of $19.04M.

Exicure Net Income Forecast

	Sep 24	Jun 24	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Jun 18
# Analysts	-	-	1	1	1	1	1	1	1	1	1	1	10	10	9	9	9	9	20
Net Income	$-1.09M	-	$18.40M	$-5.12M	$12.99K	$-611.01K	$-65.79	$-23.53M	$-14.27M	$-12.48M	$-12.69M	$-8.82M	$-4.31M	$1.15M	$-9.98M	$-5.82M	$-5.22M	$-5.29M	$-6.83M
Avg Forecast	$29.28M	$11.61M	$-18.04M	$-38.93M	$-51.91M	$-90.84M	$-181.67M	$-120.03M	$-181.67M	$-10.40M	$-134.96M	$-120.03M	$-110.30M	$2.19M	$-113.55M	$-103.81M	$-168.70M	$-5.29M	$-5.91M
High Forecast	$29.28M	$11.61M	$-18.04M	$-38.93M	$-51.91M	$-90.84M	$-181.67M	$-120.03M	$-181.67M	$-8.32M	$-134.96M	$-120.03M	$-110.30M	$2.62M	$-113.55M	$-103.81M	$-168.70M	$-4.23M	$-4.73M
Low Forecast	$29.28M	$11.61M	$-18.04M	$-38.93M	$-51.91M	$-90.84M	$-181.67M	$-120.03M	$-181.67M	$-12.48M	$-134.96M	$-120.03M	$-110.30M	$1.75M	$-113.55M	$-103.81M	$-168.70M	$-6.34M	$-7.10M
Surprise %	-0.04%	-	-1.02%	0.13%	-0.00%	0.01%	0.00%	0.20%	0.08%	1.20%	0.09%	0.07%	0.04%	0.53%	0.09%	0.06%	0.03%	1.00%	1.15%

Exicure's average Quarter net income forecast for Jun 24 is $11.61M, with a range of $11.61M to $11.61M. XCUR's average Quarter net income forecast represents a -36.86% decrease compared to the company's last Quarter net income of $18.40M (Dec 22).

Exicure SG&A Forecast

	Sep 24	Jun 24	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Jun 18
# Analysts	-	-	1	1	1	1	1	1	1	1	1	1	10	10	9	9	9	9	20
SG&A	$1.43M	-	$2.11M	$2.42M	$3.21M	$3.16M	$10.14	$2.95M	$3.10M	$2.89M	$2.73M	$2.42M	$2.23M	$2.57M	$2.15M	$2.23M	$1.99M	$2.21M	$1.99M
Avg Forecast	-	-	$-14.43M	$-14.43M	$-15.17M	$-15.91M	$-12.95M	$-25.86M	$-5.75M	$-6.08M	$-11.44M	$-8.76M	$-6.41M	$-5.30M	$-370.06K	$-925.16K	$-1.11M	$-370.06K	$-62.04K
High Forecast	-	-	$-4.38M	$-14.43M	$-15.17M	$-15.91M	$-12.95M	$-25.86M	$-5.75M	$-6.08M	$-11.44M	$-8.76M	$-6.41M	$-5.30M	$-370.06K	$-925.16K	$-1.11M	$-370.06K	$-49.63K
Low Forecast	-	-	$-24.48M	$-14.43M	$-15.17M	$-15.91M	$-12.95M	$-25.86M	$-5.75M	$-6.08M	$-11.44M	$-8.76M	$-6.41M	$-5.30M	$-370.06K	$-925.16K	$-1.11M	$-370.06K	$-74.44K
Surprise %	-	-	-0.15%	-0.17%	-0.21%	-0.20%	-0.00%	-0.11%	-0.54%	-0.48%	-0.24%	-0.28%	-0.35%	-0.49%	-5.82%	-2.41%	-1.79%	-5.97%	-32.05%

Exicure's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to XCUR last annual SG&A of $1.43M (Sep 24).

Exicure EPS Forecast

	Sep 24	Jun 24	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Jun 18
# Analysts	-	-	1	1	1	1	1	1	1	1	1	1	10	10	9	9	9	9	20
EPS	$-0.06	-	$0.56	$-1.03	-	$-0.15	-	$-8.01	$-4.86	$-4.26	$-4.33	$-3.03	$-1.48	$0.39	$-3.39	$-2.70	$-3.53	$-3.58	$-5.19
Avg Forecast	$1.54	$1.34	$-0.95	$-4.50	$-6.00	$-10.50	$-21.00	$-13.88	$-21.00	$-18.60	$-15.60	$-13.88	$-12.75	$-13.50	$-13.13	$-12.00	$-19.50	$-18.00	$-0.13
High Forecast	$1.54	$1.34	$-0.95	$-4.50	$-6.00	$-10.50	$-21.00	$-13.88	$-21.00	$-18.60	$-15.60	$-13.88	$-12.75	$-13.50	$-13.13	$-12.00	$-19.50	$-18.00	$-0.10
Low Forecast	$1.54	$1.34	$-0.95	$-4.50	$-6.00	$-10.50	$-21.00	$-13.88	$-21.00	$-18.60	$-15.60	$-13.88	$-12.75	$-13.50	$-13.13	$-12.00	$-19.50	$-18.00	$-0.16
Surprise %	-0.04%	-	-0.59%	0.23%	-0.00%	0.01%	-	0.58%	0.23%	0.23%	0.28%	0.22%	0.12%	-0.03%	0.26%	0.22%	0.18%	0.20%	39.92%

According to 0 Wall Street analysts, Exicure's projected average Quarter EPS for Jun 24 is $1.34, with a low estimate of $1.34 and a high estimate of $1.34. This represents a 139.75% increase compared to XCUR previous annual EPS of $0.56 (Dec 22).

Exicure Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
PMVP	PMV Pharmaceuticals	$1.61	$18.00	1018.01%	Buy
LIFE	aTyr Pharma	$1.90	$11.00	478.95%	Buy
MIST	Milestone Pharmaceuticals	$1.85	$10.00	440.54%	Buy
LUMO	Lumos Pharma	$4.33	$16.50	281.06%	Buy
CYCC	Cyclacel Pharmaceuticals	$0.35	$1.00	185.71%	Buy
ELYM	Eliem Therapeutics	$5.11	$13.00	154.40%	Buy
DMAC	DiaMedica Therapeutics	$4.18	$8.33	99.28%	Buy
MCRB	Seres Therapeutics	$0.73	$1.25	71.23%	Buy
XCUR	Exicure	$10.86	$12.00	10.50%	-
IKNA	Ikena Oncology	$1.73	$1.33	-23.12%	Buy

XCUR Forecast FAQ

Will Exicure stock go up soon?

According to Wall Street analysts' prediction for XCUR stock, the company can go up by 10.50% (from the last price of $10.86 to the average price target of $12), up by 10.50% based on the highest stock price target, and up by 10.50% based on the lowest stock price target.

Can Exicure stock reach $20?

XCUR's average twelve months analyst stock price target of $12 does not support the claim that Exicure can reach $20 in the near future.

What are Exicure's analysts' financial forecasts?

Exicure's analysts financial forecasts for the fiscal year (Dec 2021) are as follows: average revenue is $13.69M (high $13.69M, low $13.69M), average EBITDA is $-9.749M (high $-7.808M, low $-11.689M), average net income is $-494M (high $-492M, low $-496M), average SG&A $-50.644M (high $-50.644M, low $-50.644M), and average EPS is $-74.475 (high $-74.475, low $-74.475).

Did the XCUR's actual financial results beat the analysts' financial forecasts?

Based on Exicure's last annual report (Dec 2022), the company's revenue was $28.83M, beating the average analysts forecast of $16.2M by 77.94%. Apple's EBITDA was $-1.856M, beating the average prediction of $-45.251K by 4001.57%. The company's net income was $-2.582M, missing the average estimation of $-200M by -98.71%. Apple's SG&A was $10.89M, missing the average forecast of $-59.951M by -118.16%. Lastly, the company's EPS was $-0.56, missing the average prediction of $-21.95 by -97.45%. In terms of the last quarterly report (Dec 2022), Exicure's revenue was $21.77M, beating the average analysts' forecast of $3.9M by 458.31%. The company's EBITDA was $19.04M, beating the average prediction of $2.11K by 902459.24%. Exicure's net income was $18.4M, missing the average estimation of $-18.044M by -201.95%. The company's SG&A was $2.11M, missing the average forecast of $-14.433M by -114.60%. Lastly, the company's EPS was $0.56, missing the average prediction of $-0.95 by -158.95%